World's leading clinical conference on bone, joint and muscle health
Programme
Thursday April 11th - GMT Time zone
01:00 - 23:59
WCO-IOF-ESCEO
16:30 - 19:15
Auditorium A
WCO-IOF-ESCEO - OPENING CEREMONY
Chairpersons :
John A. Kanis
& Jean-Yves Reginster
16:30
Auditorium A
Best clinical papers published in 2023
17:10
Auditorium A
Opening
17:15
Auditorium A
Bone Health of Older People: An Emerging Public Health Priority
17:25
Auditorium A
Presentation of the ESCEO-Islene Araujo de Carvalho Award
17:30
Auditorium A
IOF 2023 Highlights
17:35
Auditorium A
ESCEO 2023 Highlights
17:40
Auditorium A
Artificial intelligence, a tribute to Alan Turing
18:10
Auditorium A
Diseases represented in paintings of the Renaissance and Baroque Period
18:40
Auditorium A
Tribute to Professor Cyrus Cooper
18:50
Auditorium A
Awards Presentation
- 18:50 Presentation of the IOF President's Award
- 18:55 Presentation of the 2024 ESCEO Medal of Excellence
- 19:00 Presentation of the 2024 IOF CSA Medal of Achievement
19:15 - 20:15
Welcome Cocktail
Friday April 12th - GMT Time zone
08:00
Opening of the Congress & commercial exhibition
08:00 - 09:00
Non-Sponsored Symposia
08:00
MR1
Treatment failure: a bad day at the office ?
Chairperson :
Michael McClung
- Unmet goals of treated patients
- Improving efficacy after poor outcomes
- Clinical perspectives after a fracture: could it be any worse?
08:00
MR2
Psoriatic disease. A multifaceted disease with musculoskeletal manifestations. Emerging therapies
Chairperson :
Panagiotis Athanassiou
- Psoriatic disease: Musculoskeletal manifestations
- Psoriatic disease: Comorbidities
- Psoriatic disease: Psychosocial implications
- Psoriatic disease and rehabilitation
- Psoriatic disease: Current treatment and emerging therapies
08:00
MR3
Digital health interventions for engaging older adults in exercise – What has been effective and what do consumers want?
Chairperson :
Mylene Aubertin-Leheudre
- Implementing physical activity for community-dwelling seniors during periods of isolation
- Short- and long-term effects of 4 online remote physical activity interventions on physical performances during isolation periods in community-dwelling older adults
- Understanding older adults’ preferences for engaging in remote interventions for improving physical function: The RAMP international consumer Delphi process
08:00
MR4
Practical ways to prevent fractures in older adults through focused geriatric assessment
Chairpersons :
Alfonso J. Cruz-Jentoft
& Antonio Cherubini
- How can the recent World Falls Guidelines be implemented to reduce fracture risk in older people
- Screening frailty easily in practice: Validation of Simpler Fried Frailty Scale in different European Countries
- Can and how medication review helps us preventing further fractures?
08:00
MR5
Beyond FRAX: important but commonly overlooked risk factors
Chairperson :
Robert Blank
- Virtually all fracture sites are associated with adverse post-fracture outcomes
- Association between Specific Multimorbidity clusters and the risk of Fracture and Post-Fracture Consequences
- Self-assessed limited mobility is associated with increased fracture risk in both women and men
08:00
MR6
Overcoming the limitations of universal vitamin D cut-offs through a novel metabolic approach
Chairperson :
Markus Herrmann
- Functional Assessment of Vitamin D Status by a Novel Metabolic Approach
- 1,25(OH)2D and 1,24,25(OH)3D – expanding our knowledge on vitamin D catabolism beyond VMR
08:00
MR7
The significance of quality indicators in Latin America
Chairperson :
Juan Carlos Viveros García
- The Burden of Hip Fractures and the Need for Quality
- Key Quality Indicators for Hip Fracture Care: What to Measure and Why
- Implementing Quality Indicators in National Healthcare Systems: Challenges and Success Stories
08:00
MR8
The role of hormones in women’s bone health and wellbeing
Chairpersons :
Maria Celeste Osorio Wender
& Adriana Orcesi Pedro
- Bone health and hormonal contraception
- How to manage the early negative impact of premature ovarian insufficiency on bone health?
- Bone health and osteoporosis screening in gynecologic cancer survivors
- Characterizing body composition and bone health in transgender individuals receiving gender-affirming hormone therapy
09:00 - 10:30
Auditorium A
Scientific Session I
Chairpersons :
Maria Luisa Brandi
& René Rizzoli
09:00
Auditorium A
Plenary Lecture 1
Fracture prevention: time to move beyond the primary/secondary dichotomy?
09:30
Auditorium A
Oral communications selected from abstracts
09:30
Auditorium A
Oral communication selected from abstracts
OC1: COMPARATIVE EFFECTIVENESS OF DENOSUMAB VERSUS BISPHOSPHONATES AMONG TREATMENT-EXPERIENCED POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS IN THE U.S. MEDICARE PROGRAM
Presenting author:
Authors:
09:40
Auditorium A
Oral communication selected from abstracts
OC2: BMD RESPONSES AT THE LUMBAR SPINE AND TOTAL HIP IN PATIENTS RECEIVING ROMOSOZUMAB, DENOSUMAB AND ALENDRONATE: A POST HOC ANALYSIS OF THE RANDOMISED FRAME AND ARCH PHASE 3 TRIALS
Presenting author:
Authors:
09:50
Auditorium A
Oral communication selected from abstracts
OC3: CARDIOVASCULAR SAFETY OF ROMOSOZUMAB IN OSTEOPOROSIS PATIENTS: A TRINETX MULTI-INSTITUTIONAL RESEARCH NETWORK ANALYSIS
Presenting author:
Authors:
10:00
Auditorium A
Oral communication selected from abstracts
OC4: THE COMPARATIVE EFFECTIVENESS AND CARDIOVASCULAR SAFETY OF ABALOPARATIDE AND TERIPARATIDE IN POSTMENOPAUSAL WOMEN NEW TO ANABOLIC THERAPY: UPDATE OF A REAL-WORLD RETROSPECTIVE
Presenting author:
Authors:
10:10
Auditorium A
Oral communication selected from abstracts
OC5: ZOLEDRONIC ACID AND DENOSUMAB ARE COMPARABLE IN DIABETIC OSTEOPOROTIC PATIENTS: A POPULATION-BASED COHORT STUDY
Presenting author:
Authors:
10:20
Auditorium A
Oral communication selected from abstracts
OC6: ANTIRESORPTIVE MEDICATION-RELATED JAW OSTEONECROSIS: AN EUROPEAN EUDRAVIGILANCE DATABASE-BASED RETROSPECTIVE COHORT STUDY
Presenting author:
Authors:
10:30 - 12:10
Auditorium A
Scientific Session II
Chairpersons :
Manju Chandran
& Nicholas Harvey
10:30
Auditorium A
Presentation of the ESCEO-IOF Pierre Delmas Medal
10:40
Auditorium A
Plenary Lecture 2
Optimization of lifelong osteoporosis management
11:10
Auditorium A
Oral communications selected from abstracts
11:10
Auditorium A
Oral communication selected from abstracts
OC7: CLINICAL IMPACT OF ACUTE SYMPTOMATIC VERTEBRAL FRACTURES IN THE UNITED STATES: AN OBSERVATIONAL STUDY
Presenting author:
Authors:
11:20
Auditorium A
Oral communication selected from abstracts
OC8: MULTIMORBIDITY AND RISK OF FALLS, FRACTURES, AND JOINT REPLACEMENTS OVER TWO DECADES: FINDINGS FROM THE HERTFORDSHIRE COHORT STUDY
Presenting author:
Authors:
11:30
Auditorium A
Oral communication selected from abstracts
OC9: TEN-YEAR FOLLOW-UP OF FRACTURE RISK IN A SYSTEMATIC POPULATION-BASED SCREENING PROGRAMME: THE RISK-STRATIFIED OSTEOPOROSIS STRATEGY EVALUATION (ROSE) RANDOMISED TRIAL
Presenting author:
Authors:
11:40
Auditorium A
Oral communication selected from abstracts
OC10: ELEVATED FRACTURE RISK IN A DANISH COHORT WITH TYPE 2 DIABETES MELLITUS AND MICROVASCULAR DISEASES
Presenting author:
Authors:
11:50
Auditorium A
Oral communication selected from abstracts
OC11: ALARMING INCREASE IN BURDEN OF SPINAL FRACTURE IN THE MIDDLE EAST AND NORTH AFRICA: A 30-YEAR SECONDARY ANALYSIS OF THE GLOBAL BURDEN OF DISEASE STUDY 2019
Presenting author:
Authors:
12:00
Auditorium A
Oral communication selected from abstracts
OC12: DIMINISHING RETURNS OF FALL PREVENTION ON HIP FRACTURE WITH AGE
Presenting author:
Authors:
12:15 - 13:45
Auditorium A
Sponsored Lunch Satellite Symposium
12:15 - 13:45
Auditorium B
Sponsored Lunch Satellite Symposium
14:00 - 15:00
Meet-The-Expert Session
14:00
MR1
Complex osteoporosis: case histories
14:00
MR2
Guidelines for management of hypoparathyroidism
14:00
MR3
Machine learning and computer vision - the future of fracture risk assessment?
14:00
MR4
An integrated approach to nutrition in musculoskeletal disease
14:00
MR6
‘omics in the future of bone health assessment
14:00
MR7
Guidelines for management of primary hyperparathyroidism
14:00
MR8
How can we optimize fracture healing?
14:00 - 15:00
Podium
Oral presentations of selected posters
Chairperson :
K. A. Ward
14:00
Podium
P683
EFFICACY AND SAFETY OF CT-P41, A PROPOSED DENOSUMAB BIOSIMILAR, COMPARED TO REFERENCE DENOSUMAB (PROLIA) IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
Presenting author:
Authors:
14:06
Podium
P1394
BISPHOSPHONATES SHOW NO ASSOCIATION WITH PREVENTING, SLOWING, OR DELAYING RADIOGRAPHIC CHANGES AND PAIN IN HIP OSTEOARTHRITIS: A FOUR-YEAR STUDY IN FEMALE ADULTS USING DATA FROM THE OSTEOARTHRITIS INITIATIVE STUDY
Presenting author:
14:12
Podium
P504
ROMOSOZUMAB AND DENOSUMAB COMBINATION THERAPY IN POSTMENOPAUSAL OSTEOPOROSIS
Presenting author:
Authors:
14:18
Podium
P512
RELATIONSHIPS BETWEEN SELF-PERCEIVED FRACTURE RISK AND FAMILY HISTORY IN THE HERTFORDSHIRE INTERGENERATIONAL STUDY – THE SAME OR DIFFERENT TO PERCEPTIONS REGARDING HEART DISEASE RISK?
Presenting author:
Authors:
14:24
Podium
P674
TREATMENT WITH LORECIVIVINT LEADS TO IMPROVED LONG-TERM PATIENT ACCEPTABLE SYMPTOM STATE (PASS) COMPARED TO PLACEBO: DATA FROM PHASE 3 EXTENSION TRIAL
Presenting author:
Authors:
14:30
Podium
P1167
EFFECT OF ROMOSOZUMAB ON TISSUE THICKNESS–ADJUSTED TRABECULAR BONE SCORE (TBSTT) IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS AND DIABETES: RESULTS FROM THE ARCH STUDY
Presenting author:
Authors:
14:36
Podium
P488
RELATIONSHIPS BETWEEN EARLY LIFE FACTORS AND OSTEOARTHRITIS PAIN: FINDINGS FROM THE HERTFORDSHIRE COHORT STUDY
Presenting author:
Authors:
14:42
Podium
P935
INCREASED BONE MARROW ADIPOSITY IS RELATED TO HIGHER FRACTURE RISK AND LOWER BONE MINERAL DENSITY IN OLDER SWEDISH WOMEN
Presenting author:
Authors:
14:48
Podium
P321
HEALTH-RELATED QUALITY OF LIFE IN SARCOPENIA: CONTENT VALIDITY OF THE SARQOL QUESTIONNAIRE.
Presenting author:
Authors:
14:54
Podium
P360
WHAT IS THE EFFECT OF HORMONE REPLACEMENT THERAPY (HRT) ON PREVALENCE, INCIDENCE, AND SEVERITY OF OSTEOARTHRITIS (OA) OF THE KNEE, HIP AND HANDS? A SYSTEMATIC REVIEW
Presenting author:
Authors:
14:00 - 15:00
Poster Area
Poster Viewing Session I
14:00 - 15:00
Auditorium B
Sponsored Meet-The-Expert Session
14:00 - 15:00
MR5
WHO SYMPOSIUM
WHO Symposium on Bone Health and Ageing
Chairpersons :
Anshu Banerjee
& René Rizzoli
- Overview of WHO Technical Work on Bone Health and Ageing
- Systematic review of Measurement Properties of instruments to measure the quality of life of older persons with Sarcopenia and Osteoporosis
- Systematic Review of Measurement Properties of Instruments to Assess Risk of Fracture in Older Persons – An update
- WHO Global Report on Fractures among Older Persons: An overview
- Reflections
15:00 - 17:00
Auditorium A
Scientific Session III
Chairpersons :
Jean-Marc Kaufman
& Patricia Clark
15:00
Auditorium A
Plenary Lecture 3
Unravelling the vitamin D megatrial conundrum
15:30
Auditorium A
Oral communications selected from abstracts
15:30
Auditorium A
Oral communication selected from abstracts
OC13: PREDICTING THE ONSET OF END-STAGE KNEE OSTEOARTHRITIS OVER TWO- AND FIVE-YEARS USING MACHINE LEARNING
Presenting author:
Authors:
15:40
Auditorium A
Oral communication selected from abstracts
OC14: MILD COGNITIVE IMPAIRMENT PREDICTS THE ONSET OF SARCOPENIA: A LONGITUDINAL ANALYSIS FROM THE ENGLISH LONGITUDINAL STUDY ON AGEING
Presenting author:
Authors:
15:50
Auditorium A
Oral communication selected from abstracts
OC15: COMPARATIVE EFFECTIVENESS OF YOGA AND STRENGTHENING EXERCISE FOR TREATING KNEE OSTEOARTHRITIS: A RANDOMISED CONTROLLED TRIAL (YOGA TRIAL)
Presenting author:
Authors:
16:00
Auditorium A
Oral communication selected from abstracts
OC16: RADIOGRAPHIC AND PAIN OUTCOMES FROM A PHASE 3 EXTENSION STUDY (OA-07) EVALUATING THE SAFETY AND EFFICACY OF REPEAT LORECIVIVINT INJECTIONS OVER 3 YEARS IN SUBJECTS WITH SEVERE KNEE OSTEOARTHRITIS
Presenting author:
Authors:
16:10
Auditorium A
Oral communication selected from abstracts
OC17: CURRENT SARCOPENIA DEFINITIONS ARE NOT VALID FOR PREDICTING FALLS AND POOR PHYSICAL FUNCTION IN URBAN DWELLING OLDER ADULTS IN SOUTH AFRICA, THE GAMBIA AND ZIMBABWE: RESULTS FROM THE MUFASSA STUDY
Presenting author:
Authors:
16:20
Auditorium A
Oral communication selected from abstracts
OC18: INCREASED RISK OF STROKE IN PATIENTS WITH OSTEOARTHRITIS IN A PROSPECTIVE COHORT OF MEN : THE STRAMBO STUDY
Presenting author:
Authors:
16:30
Auditorium A
Plenary Lecture 4
Bone, biochemistry and beyond: new paradigms in CKD MBD
15:00 - 16:45
MR5
Committee of National Societies Special Plenary Session
Chairperson :
Famida Jiwa
15:00
MR5
Tribute to Professor Gemma ADIB, a pioneer in the fight against osteoporosis in the Middle East region
15:10
MR5
OCs1: VARIATIONS IN HOSPITAL LENGTH OF STAY AND PERFORMED SURGICAL PROCEDURES AFTER HIP FRACTURES
Presenting author:
Authors:
15:18
MR5
OCs2: LESSONS FROM RICO: RISK COMMUNICATION IN OSTEOPOROSIS STUDY
Presenting author:
Authors:
15:26
MR5
OCs3: FROM PIXELS TO PREVENTION: AI-POWERED DIGITAL RADIOGRAMMETRY DEMOCRATIZES OSTEOPOROSIS DIAGNOSIS
Presenting author:
Authors:
15:34
MR5
OCs4: VERTEBRAL FRACTURES BY DXA: IS THE CURRENT DEFINITION ADEQUATE?
Presenting author:
Authors:
15:42
MR5
OCs5: ANXIETY AND DEPRESSION ARE ASSOCIATED WITH POOR HEALTH BEHAVIOURS AND INCIDENT FRACTURE AMONG WOMEN: FINDINGS FROM THE HERTFORDSHIRE COHORT STUDY
Presenting author:
Authors:
15:50
MR5
Presentation of the IOF Committee of National Societies Medal
16:00
MR5
OCs6: BONE MINERAL DENSITY AND HAND GRIP STRENGTH IN POSTMENOPAUSAL WOMEN WITH FOREARM FRACTURES
Presenting author:
Authors:
16:08
MR5
OCs7: ORTHOGERIATRIC CO-MANAGEMENT FOR OLDER PATIENTS WITH A MAJOR OSTEOPOROTIC FRACTURE: AN OBSERVATIONAL PRE-POST STUDY
Presenting author:
Authors:
16:16
MR5
OCs8: UNITING THE DICHOTOMY BETWEEN PRIMARY AND SECONDARY PREVENTION OF OSTEOPOROSIS – A COMMUNITY- BASED INTERVENTION
Presenting author:
Authors:
16:24
MR5
OCs9: HAND GRIP STRENGTH IN PATIENTS WHO DIAGNOSED WITH TYPE 2 DIABETES MELLITUS IN MONGOLIAN FAMILY HEALTH CENTER
Presenting author:
Authors:
16:32
MR5
OCs10: MACHINE LEARNING TO CHARACTERIZE BONE BIOMARKERS PROFILE IN RHEUMATOID ARTHRITIS
Presenting author:
Authors:
17:00 - 18:30
Auditorium A
Sponsored Satellite Symposium
18:30 - 19:30
Non-Sponsored Symposia
18:30
MR1
Clinical management of patients on anabolic therapy for osteoporosis
Chairperson :
Bruno Muzzi Camargos
- Follow-up through imaginological assessment: aDXA, TBS, RX, VFA, 3D-DXA and QCT
- Clinical management of patients under anabolic therapy
18:30
MR2
Update in diagnosis and management of fibromyalgia syndrome on the basis of evidence based medicine
Chairpersons :
Fitnat Dincer
& Andreas Winkelmann
- Update in Diagnosis of Fibromyalgia Syndrome on the Basis of Evidence based Medicine
- Update in Pharmacological Management of FMS on the Basis of Evidence Based Medicine
- Update in Non -Pharmacological Management of FMS on the Basis of Evidence Based Medicine
18:30
MR3
Skeletal Fragility: new era in the management of the CKD patients
Chairpersons :
Hanne Jorgensen
& Serge Ferrari
- KDIGO: what’s news in CKD-MBD
- The Association between Vertebral Fractures and Vascular Calcifications in Patients without and with CKD
- Bone Biopsy: How, When and Why perform it in CKD patients
18:30
MR4
Vitamin D in rheumatic diseases
Chairpersons :
Osvaldo Daniel Messina
& Jorge L. A. Morales Torres
- Epidemiology of VD in Rheumatic diseases
- Vitamin D and Systemic Lupus Erythematosus, Antiphospholipid syndrome, and Systemic Sclerosis
- Vitamin D levels in patients with rheumatoid arthritis
18:30
MR7
Artificial intelligence in osteoporosis: including a case study of vertebral fracture detection
Chairpersons :
Nicholas R. Fuggle
& Kassim M. Javaid
- What is ‘Clinical AI’ and how is it used in Osteoporosis?
- Ethical Considerations when using of AI in Clinical Practice
- Artificial Intelligence in Osteoporosis: including a case study of vertebral fracture detection: AI for vertebral fracture screening: A UK perspective – Findings of the ADOPT study
Saturday April 13th - GMT Time zone
08:00 - 09:00
Non-Sponsored Symposia
08:00
MR3
Osteoporosis and atherosclerotic heart disease
Chairperson :
Peter R. Ebeling
- Vascular-Bone Nexus: A narrative review of the Evidence from epidemiological Studies and randomized controlled Trials
- A model for Bone as the Source of Calcification in Atherosclerotic Heart Disease
08:00
MR4
Insights into ageing: lessons from the senior and sarcophage cohorts on frailty and sarcopenia
Chairperson :
Olivier Bruyère
- SENIOR contributions to frailty, nutrition and physical activity
- SarcoPhAge contributions to sarcopenia, malnutrition and quality of life
- The SENIOR and SarcoPhAge cohorts to study COVID and long-term mortality
- Conclusion and questions
08:00
MR5
Capture the Fracture® : global perspectives and experience
Chairpersons :
Nicholas Harvey
& Maria Luisa Brandi
- Global Experiences in FLS Implementation and secondary fracture prevention in policy – Asia-Pacific
- Global Experiences in FLS Implementation and secondary fracture prevention in policy – Europe
- Global Experiences in FLS Implementation and secondary fracture prevention in policy – North America
- Global Experiences in FLS Implementation and secondary fracture prevention in policy – Latin America
08:00
MR6
The fatal attraction of cancer and bone
Chairpersons :
Janet Brown
& Peyman Hadji
- Treatment induced Osteoporosis in women with breast cancer
- Treatment induced Osteoporosis in men with prostate cancer
- Current guideline dependent treatment of bone metastasis
08:00
MR7
Sarcopenia state-of-the-art: components, definitions and global impact
Chairpersons :
Elaine M. Dennison
& Elizabeth M. Curtis
- Sarcopenia components and definitions: prevalence, agreement and predictive capacity regarding mortality
- Sarcopenia components and definitions as predictors of fracture risk
- Prevalence and burden of sarcopenia in sub-Saharan Africa
08:00
MR8
Assessment of risk of falls and fracture in older women: project in primary care in women’s health
Chairperson :
Bruno Muzzi Camargos
- Construction of a project to assess the risk of falls based on women’s musculoskeletal physiology
- Development of a fall risk assessment protocol based on musculoskeletal and comprehensive assessment: protocols and main results
08:00 - 09:00
MR2
DVO-ESCEO Joint Symposium
The DVO Concept to provide Care for Patients with Osteoporosis and Bone Diseases in German speaking countries
Chairpersons :
John A. Kanis
& Ralf Schmidmaier
- The new DVO guidelines for osteoporosis 2023 – a paradigm change for the german speaking countries
- Disease Management Program Osteoporosis - a politically decided structured care program for Germany
- A new case finding algorithm according to fracture risk
- Medical education in Osteology care: from basic research to clinical competence certification
09:00 - 10:30
Auditorium A
Scientific Session IV
Chairpersons :
Bess Dawson-Hughes
& Olivier Bruyère
09:00
Auditorium A
Plenary Lecture 5
Bone resorption inhibitors beyond the skeleton
09:30
Auditorium A
Oral communications selected from abstracts
09:30
Auditorium A
Oral communication selected from abstracts
OC19: DXA-DERIVED HIP SHAPE IS PREDICTIVE OF HIP FRACTURE: A LONGITUDINAL STUDY FROM UK BIOBANK
Presenting author:
Authors:
09:40
Auditorium A
Oral communication selected from abstracts
OC20: GREATER THIGH MUSCLE MASS MEASURED BY MRI IS ASSOCIATED WITH REDUCED INCIDENT FRACTURE RISK IN WOMEN, BUT NOT MEN: FINDINGS FROM THE UK BIOBANK
Presenting author:
Authors:
09:50
Auditorium A
Oral communication selected from abstracts
OC21: HIP GEOMETRY AND FRACTURE AMONG IRISH MEN AND WOMEN: THE DXA HIP PROJECT
Presenting author:
Authors:
10:00
Auditorium A
Oral communication selected from abstracts
OC22: COST-EFFECTIVENESS OF RADIOFREQUENCY ECHOGRAPHIC MULTI SPECTROMETRY (REMS) FOR THE DIAGNOSIS OF OSTEOPOROSIS IN THE UNITED STATES
Presenting author:
Author:
10:10
Auditorium A
Oral communication selected from abstracts
OC23: EXTERNAL VALIDATION OF AI-DRIVEN BONE FRAGILITY DETECTION IN RADIOGRAPHS FROM MULTINATIONAL COHORTS
Presenting author:
Authors:
10:20
Auditorium A
Presentation of the ESCEO-IOF Pierre Meunier Young Scientist Award
10:30 - 12:10
Auditorium A
Scientific Session V
Chairpersons :
Charlotte Beaudart
& Eugene V. McCloskey
10:30
Auditorium A
Presentation of the IOF Olof Johnell Science Award
10:40
Auditorium A
Plenary Lecture 6
Management of osteoporosis in multi-ethnic societies
11:10
Auditorium A
Oral communications selected from abstracts
11:10
Auditorium A
Oral communication selected from abstracts
OC24: VITAMIN D METABOLITE RATIO (VMR) OFFERS THE BEST APPROACH TO EVALUATE FUNCTIONAL VITAMIN D DEFICIENCY: RESULTS OF THE SARCOPHAGE STUDY
Presenting author:
Authors:
11:20
Auditorium A
Oral communication selected from abstracts
OC25: CALCITRIOL SUPPLEMENTATION AFTER KIDNEY TRANSPLANTATION: RESULTS OF A DOUBLE-BLINDED, RANDOMIZED, PLACEBO-CONTROLLED TRIAL
Presenting author:
Authors:
11:30
Auditorium A
Oral communication selected from abstracts
OC26: FRACTURE LIAISON SERVICES AND SUBSEQUENT FRACTURE RISK: A MULTICENTER, PRAGMATIC, STEPPED-WEDGE CLUSTER-RANDOMIZED CONTROLLED TRIAL
Presenting author:
Authors:
11:40
Auditorium A
Oral communication selected from abstracts
OC27: PROTON PUMP INHIBITORS ASSOCIATED WITH INCREASED BONE TURNOVER MARKERS: RESULTS OF A LARGE OBSERVATIONAL COHORT STUDY
Presenting author:
Authors:
11:50
Auditorium A
Oral communication selected from abstracts
OC28: DISCONTINUATION OF BISPHOSPHONATES IN OLDER PEOPLE WITH COMPLEX HEALTH NEEDS: SELF-CONTROLLED CASE SERIES TO ASSESS FRACTURE RISK
Presenting author:
Authors:
12:15 - 13:45
Auditorium A
Sponsored Lunch Satellite Symposium
12:15 - 13:45
Auditorium B
Sponsored Lunch Satellite Symposium
14:00 - 15:00
Meet-The-Expert Session
14:00
MR4
Critical role of exercise in post fracture management
14:00
MR7
Transgender medicine: key challenges in the management of musculoskeletal disease
14:00
MR8
Achieving optimal musculoskeletal health in HIV
14:00 - 15:00
Podium
Oral presentations of selected posters
Chairperson :
K. A. Ward
14:00
Podium
P1091
GUT MICROBIOTA AND SHORT-CHAIN FATTY ACID SIGNATURES IN POSTMENOPAUSAL OSTEOPOROSIS PATIENTS:A RETROSPECTIVE STUDY
Presenting author:
Authors:
14:06
Podium
P1122
EXPECTED LOSS OF PRODUCTIVITY FOLLOWING FRAGILITY FRACTURES IN PATIENTS OF WORKING AGE
Presenting author:
Authors:
14:12
Podium
P228
THE ICARE FEASIBILITY STUDY: AN INTEGRATED COLLECTION OF EDUCATION MODULES FOR FALL AND FRACTURE PREVENTION FOR HEALTHCARE PROVIDERS IN LONG TERM CARE
Presenting author:
Authors:
14:18
Podium
P754
ANXIETY AND DEPRESSION ARE ASSOCIATED WITH POOR HEALTH BEHAVIOURS AND INCIDENT FRACTURE AMONG WOMEN: FINDINGS FROM THE HERTFORDSHIRE COHORT STUDY
Presenting author:
Authors:
14:24
Podium
P863
BONE MINERAL DENSITY POST-TREATMENT FOLLOW-UP IN WOMEN WITH ENDOMETRIOSIS TREATED WITH RELUGOLIX COMBINATION THERAPY: SPIRIT PROGRAMME
Presenting author:
Authors:
14:30
Podium
P679
COMPARATIVE ANALYSIS OF TERIPARATIDE AND ROMOSOZUMAB IN PREVENTING SYMPTOMATIC SUBSEQUENT VERTEBRAL COMPRESSION FRACTURE AFTER CEMENTING
Presenting author:
Authors:
14:36
Podium
P1136
STANDARD X-RAY IMAGES MAY POTENTIALLY BE USED TO QUANTIFY BONE DISORGANIZATION AND IDENTIFY PATIENTS WITH HYPOPHOSPHATASIA
Presenting author:
Authors:
14:42
Podium
P280
ASSESSMENT OF ADHERENCE TO ANTI-OSTEOPOROTIC MEDICATION (AOM) TREATMENT IN THE RISK-STRATIFIED OSTEOPOROSIS STRATEGY EVALUATION (ROSE) SCREENING PROGRAMME: A TEN-YEAR FOLLOW-UP STUDY
Presenting author:
Authors:
14:48
Podium
P1013
THE EFFECT OF EIGHT MONTHS OF BALLISTIC AND CONVENTIONAL RESISTANCE EXERCISE TRAINING ON BONE STRENGTH IN POSTMENOPAUSAL WOMEN: THE REPROOF STUDY
Presenting author:
Authors:
14:54
Podium
P142
CALCIUM (CA) ISOTOPE COMPOSITION IN SERUM AND URINE FOR THE ASSESSMENT OF BONE CALCIUM BALANCE (BCAB) – RESULTS FROM A POST-MARKET SURVEILLANCE CLINICAL FOLLOW-UP STUDY ON 2409 PARTICIPANTS
Presenting author:
Authors:
14:00 - 15:00
Poster Area
Poster Viewing Session II
14:00 - 15:00
Auditorium B
Sponsored Educational Lecture
14:00 - 15:00
MR1
EUGMS-ESCEO Joint Symposium
Improving fragility fracture care: a multidisciplinary perspective
Chairperson :
Tahir Masud
- Optimizing fracture prevention and rehabilitation in frail older persons: the exercise & physiotherapy perspective
- Optimizing fracture prevention and rehabilitation in frail older persons: the nursing & care home perspective
14:00 - 15:00
MR2
OARSI-ESCEO Joint Symposium
Managing Bone and Joint Diseases in Older Aged: Epidemiology and Lessons for the Clinic
Chairpersons :
Gun-il Im
& Elizabeth M. Curtis
- Immunometabolic Alterations Linking Diabetes Osteoarthritis and Osteoporosis
- Impact of Osteoporosis and Osteoarthritis as Comorbidities in the Aging Population
14:00 - 15:00
MR5
ESCEO Symposium
ESCEO Working Group on “REMS in the diagnosis and management of osteoporosis: State of the art”
Chairpersons :
Radmila Matijevic
& Andreas Kurth
- REMS : How does it work and what do we measure?
- What is the contribution of REMS to the management of post-menopausal osteoporosis?
- What is the contribution of REMS in the management of musculoskeletal health, outside of post-menopausal osteoporosis?
- Discussion
15:00 - 17:00
Auditorium A
Scientific Session VI
Chairpersons :
Jean-Yves Reginster
& Radmila Matijevic
15:00
Auditorium A
Plenary Lecture 7
How should we define sarcopenia? Past, present and future perspectives
15:30
Auditorium A
Oral communications selected from abstracts
15:30
Auditorium A
Oral communication selected from abstracts
OC29: GLOBAL BALANCE OF THE SPINE, AN INDEPENDENT CONTRIBUTOR TO PHYSICAL IMPAIRMENTS AND PREDICTOR OF INCIDENT FALLS IN OLDER ADULTS: THE SAFE 3-YEAR LONGITUDINAL COHORT STUDY
Presenting author:
Authors:
15:40
Auditorium A
Oral communication selected from abstracts
OC30: A NOVEL DRUG COMBINATION WITH THERAPEUTIC POTENTIAL FOR SARCOPENIA
Presenting author:
Authors:
15:50
Auditorium A
Oral communication selected from abstracts
OC31: IMMINENT FRACTURE RISK AND MORTALITY DIFFER BY INDEX FRACTURE SITE AND BONE MINERAL DENSITY
Presenting author:
Authors:
16:00
Auditorium A
Oral communication selected from abstracts
OC32: EFFECT OF FRAXPLUS ADJUSTMENTS ON FRACTURE RISK RECLASSIFICATION IN OLDER SWEDISH WOMEN – RESULTS FROM THE SUPERB-STUDY
Presenting author:
Authors:
16:10
Auditorium A
Oral communication selected from abstracts
OC33: SMOKING HISTORY AND FRACTURE RISK: A META-ANALYSIS TO UPDATE THE FRAX® RISK ASSESSMENT TOOL
Presenting author:
Authors:
16:20
Auditorium A
Oral communication selected from abstracts
OC34: QUANTITATIVE MOTION ARTEFACT GRADING IN HR-PQCT CLINICAL IMAGING: AN ALGORITHMIC APPROACH
Presenting author:
Authors:
16:30
Auditorium A
Plenary Lecture 8
Sarcopenia management: muscle-targeted interventions for healthy ageing
15:00 - 16:45
MR5
Committee of Scientific Advisors Special Session
IOF CSA Special Session 2024: Hip fracture to marrow adiposity and hypophosphatasia: advances in understanding skeletal disease
Chairpersons :
Nicholas Harvey
& Eugene V. McCloskey
- Optimisation of hip fracture services: lessons from the REDUCE Study
- Bone marrow adiposity: new understanding in osteoporosis pathogenesis
- State-of-the-art in hypophosphatasia: recent recommendations from international working groups
17:00 - 18:00
Non-Sponsored Symposia
17:00
MR1
How to write a good review article
Chairpersons :
Olivier Bruyère
& Nasser Al-Daghri
- How to write a narrative review
- How to write a systematic review and meta-analysis
- How to write an umbrella review
17:00
MR2
Understanding exercise for osteoporosis
Chairperson :
Belinda R. Beck
- The principles of osteogenic loading
- Translation of osteogenic principles into effective exercise prescription
17:00
MR3
Information and knowledge impact risk perception and awareness of musculoskeletal diseases – a path toward effectiveness
Chairperson :
Fatjona Kamberi
- Knowledge, risk perception, and impact on engagement in the prevention of musculoskeletal diseases – the focus group on Vitamin D
- Self-education in chronic patients with musculoskeletal conditions
- Physiotherapy in Osteoporosis. Practice behaviors and Physiotherapists’ perceptions in Albania
- Evaluation of Knowledge on the Impact of Vitamin D on Osteoarthritis
17:00
MR4
Primary hyperparathyroidism as a cause of osteoporosis. Diagnosis and management
Chairpersons :
Panagiotis Athanassiou
& Ifigenia Kostoglou-Athanassiou
- Primary hyperparathyroidism. Etiology and clinical manifestations
- Primary hyperparathyroidism and psychological implications
- Primary hyperparathyroidism and muscular effects
- Primary hyperparathyroidism and osteoporosis. The role of exercise
- Primary hyperparathyroidism and osteoporosis. Management
17:00
MR5
Osteoporosis treatment beyond 10 years
Chairperson :
Bruno Muzzi Camargos
- Long-term treatment of Osteoporosis: What’s up on 10-years after
- Discontinuation of Anti-Osteoporosis Treatments: Should we do it, when and how
- Recommendations for Osteoporosis treatment beyond 10 years
17:00
MR6
Bone health and vitamin D metabolism in chronic rheumatic diseases. Fibromyalgia and bone.
Chairpersons :
Willem Lems
& Osvaldo Daniel Messina
- Chronic arthritides and Bone
- Vitamin D in patients with inflammatory rheumatic diseases
- Fibromyalgia and bone
17:00
MR7
How to optimize bone health in athletes?
Chairperson :
Sansin Tüzün
- Scope of the Problem: Beyond the Female Athlete Triad
- Assessment of Bone Strength in Athletes
- How can REMS be helpful to assess bone in Sports Medicine?
- How to Manage Bone Loss in Athletes?
17:00
MR8
Platelet-rich plasma in musculoskeletal pathologies
Chairperson :
Jean-François Kaux
- Qualitative aspects of platelet-rich plasma injections
- Nerve anaesthesia for painful platelet-rich plasma injection
- Post-procedure after platelet-rich plasma injection for a tendinopathy
Sunday April 14th - GMT Time zone
08:00 - 09:00
Non-Sponsored Symposia
08:00
MR2
Sarcopenia in metabolic and neurological diseases
Chairpersons :
Panagiotis Athanassiou
& Yannis Dionyssiotis
- Introduction in Sarcopenia
- Sarcopenia in Metabolic Diseases
- Sarcopenia in Diabetes Mellitus
- Sarcopenia in Neurological Disorders
08:00
MR3
Neurocardiovascular disease and osteoporosis: recently met or a long relationship?
Chairperson :
Geraldine Altamar Canales
- Osteoporosis and cardiovascular risk: old friends?
- Osteoporosis and dementia: where are we going?
- Treatments for osteoporosis and cardiovascular events: what do we know?
08:00
MR4
Managing pregnancy-and lactation-associated osteoporosis
Chairpersons :
Maria Luisa Brandi
& Nicholas Harvey
- Bone fragility and osteoporosis in young adults
- Assessment of bone health in pregnancy
- Management of bone fragility in pregnant women
08:00
MR6
Bone health solutions: maybe it’s time for a change?
Chairperson :
P. Dean Cummings
- The Critical Shift to a Proactive Approach to Bone Health
- Optimal Clinical Paradigm: 4-Pillar Evaluation, Integrated Profile, and Multidisciplinary Care Plan
- Bone Health Solutions
08:00
MR7
Navigating heterogeneity in vitamin D supplementation: implications for regional health - a Latin American perspective
Chairperson :
José Francisco Torres Naranjo
- Vitamin D Status and Diverse Medical Practices in Mexico and Latin America
- Global and Regional Dynamics: Heterogeneity in Vitamin D Supplementation Across Latin America
- Formulating Unity: Mexico's Approach to the National Joint Position
08:00
MR8
Fractures-E3 study: fractures in Sub-Saharan Africa – epidemiology, ethnography and economic impact
Chairpersons :
Tereza Hough
& Tafadzwa Madanhire
- The impact of menopause and HIV on midlife bone health
- The challenges of poor musculoskeletal health in The Gambia
- Hip fracture incidence and outcomes in Zimbabwe
- The economic impact of hip fracture in Zimbabwe and South Africa
08:00 - 09:00
MR5
SICOT-ESCEO-IOF Symposium
Surgical Treatment of Fragility Fractures
Chairperson :
Ilir Hasani
- Osteoporotic Spine Fractures
- Trends in the management of osteoporotic pelvic fractures
- Will a treatment Protocol including OF classification provide clear guidelines for osteoporotic thoracolumbar fracture management? Can we avoid overtreatment or undertreatment?
- Osteoporotic Hip Fracture
- Discussion
09:00 - 10:00
Meet-The-Expert Session
09:00
MR3
Denosumab cessation: a practical approach in long-term treatment
09:00
MR4
Quality of life assessment in sarcopenia - Lessons for cohort and clinic
09:00
MR5
Phosphate wasting for the osteoporosis doctor
09:00
MR6
Management of GIOP in Latin America
09:00 - 10:00
Poster Area
Poster Viewing Session III
10:00 - 12:00
Auditorium A
Scientific Session VII
Chairpersons :
Salvatore Minisola
& Etienne Cavalier
10:00
Auditorium A
Plenary Lecture 9
New perspectives in osteoarthritis management
10:30
Auditorium A
Presentation of the ESCEO-IOF Young Investigator Awards
10:40
Auditorium A
Oral communications selected from abstracts
10:40
Auditorium A
Oral communication selected from abstracts
OC35: FRACTURE RATE AND LOCATION IN ADULTS WITH HYPOPHOSPHATASIA WITH ONE VERSUS MULTIPLE ALPL VARIANTS: DATA FROM THE GLOBAL HPP REGISTRY
Presenting author:
Authors:
10:50
Auditorium A
Oral communication selected from abstracts
OC36: IS THERE AN ASSOCIATION BETWEEN BIRTH WEIGHT OR GESTATIONAL AGE AND FRACTURE RISK IN YOUNG ADULTS?
Presenting author:
Authors:
11:00
Auditorium A
Oral communication selected from abstracts
OC37: AIR POLLUTION AND BONE HEALTH OUTCOMES: PERIODS OF SUSCEPTIBILITY FROM PREGNANCY TO CHILDHOOD
Presenting author:
Authors:
11:10
Auditorium A
Oral communication selected from abstracts
OC38: FAMILY HISTORY OF FRACTURE AND FRACTURE RISK: A META-ANALYSIS TO UPDATE THE FRAX® RISK ASSESSMENT TOOL
Presenting author:
Authors:
11:20
Auditorium A
Oral communication selected from abstracts
OC39: SEX DEPENDENT ASSOCIATIONS BETWEEN BMI AND FRACTURE RISK: AN INTERNATIONAL META-ANALYSIS
Presenting author:
Authors:
11:30
Auditorium A
Plenary Lecture 10
Precision medicine approaches in the assessment of fracture risk
12:00 - 13:00
Non-Sponsored Symposia
12:00
MR1
Patient and public involvement and engagement (PPI/E) in musculoskeletal research: an idea whose time has firmly come (and we are sharing the resources to help you get started)
Chairperson :
Angie Botto-van Bemden
- WHY; Introduction to PPI, overview of impact and progress
- WHAT; PPI Article Collection as a global resource
- HOW; Implementing patient partnerships
- WHERE we are going; PPI opportunities
12:00
MR2
Hyperthyroidism and osteoporosis
Chairperson :
Ifigenia Kostoglou-Athanassiou
- Hyperthyroidism. Etiology and clinical manifestations
- Hyperthyroidism. Psychosocial implications
- Hyperthyroidism and sarcopenia
- Hyperthyroidism and osteoporosis. Pathophysiology and management
12:00
MR3
Bone health and the spine: opportunities to drive public and health care professional education and action
Chairperson :
Rita Roy
- Osteoporosis and the Spine: Key Statistics and an Overview of the National Spine Health Foundation’s Key Patient and Health Care Professional Initiatives
- A Spine Surgeon Perspective on the Need for Perioperative Spine and Bone Health Optimization
- Spine and Bone Health Patient Educational Gaps and Needs
- A European Perspective on Key Spine Surgeon Gaps in the Diagnosis and Treatment of Osteoporotic Patients
12:00
MR4
Glucocorticoids in the treatment of rheumatoid arthritis. Friend or foe?
Chairpersons :
Osvaldo Daniel Messina
& Giovanni Adami
- GCS in the treatment of rheumatoid arthritis. Friends
- Glucocorticoids “foe”
12:00
MR5
Clinical conundrums – bone health management in special scenarios
Chairperson :
Muhammad Nisar
- Managing eGFR and bone
- Managing Aromatase inhibitor induced bone loss
12:00
MR6
Osteoporosis and cardiovascular disease: new insight
Chairperson :
Sekib Sokolovic
- Osteocalcin: Old-New Marker- Can it be prognostic for CVD?
- The Hidden upstairs between Bone density and Cardiovascular Mortality
- Osteoporosis and Cardiovascular Diseases: A case-series study
12:00
MR7
Fracture prevention strategies and antiosteoporotic medications in elderly population
Chairpersons :
Pınar Borman
& Belgin Karaoglan
- Prevention of Hip Fractures
- Antiosteoporotic Agents and Fracture Healing
- Rehabilitation of Hip Fractures
12:00
MR8
Osteoporosis: impact on health & economics
Chairpersons :
Yasser El Miedany
& Mathias Toth
- Health Economics of Osteoporosis: The missed interventional threshold
- Direct cost of osteoporotic Hip fractures
- Economic Evaluation of FLS in Egypt